Rare diseases
Investigational molecules
Locations
Back to France149 clinical trials in Orléans, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on Oxaliplatin and Irinotecan for Patients with Metastatic Colorectal Cancer in the Liver
FranceStudy of Ivosidenib or Enasidenib with Chemotherapy for Patients with Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with IDH1 or IDH2 Mutation
FranceStudy of Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
FranceStudy on Switching to Emtricitabine, Tenofovir Alafenamide, and Bictegravir for HIV-1 Patients Unable or Unwilling to Continue Injectable Therapy
FranceStudy on TAR-200 and Cetrelimab for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Who Have Not Received BCG Treatment
FranceStudy on Switching to Islatravir and MK-8507 for Adults with HIV-1 Who Are Virologically Suppressed on a Drug Combination
FranceStudy on the Effects of QUC398 for Patients with Knee Osteoarthritis
FranceStudy of Secukinumab for Maintaining Remission in Patients with Non-Radiographic Axial Spondyloarthritis
FranceStudy on the Effectiveness of Enlicitide Chloride in Reducing Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease
FranceStudy on Benralizumab for Patients with Severe Asthma
FranceFranceStudy of Cefazolin for Patients on Chronic Hemodialysis with Infections
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative studies focusing on autoimmune conditions including trials evaluating new treatments for psoriatic and rheumatoid arthritis. Research includes assessment of maintenance therapies and novel drug combinations.
Particular emphasis on evaluating long-term treatment efficacy and bone erosion prevention.
Comprehensive research in hematologic malignancies and solid tumors, with significant focus on multiple myeloma and breast cancer treatment innovations.
Advanced treatment protocols combining immunotherapy with traditional approaches.
Cutting-edge studies in HIV treatment and viral infections, exploring new therapeutic approaches and treatment optimization strategies.
Focus on developing long-acting treatments and improving patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
